| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.41 | 0.02 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |